8
LIVE

Serial Number

90785551

Owner

In8bio, Inc.

Attorney

Mark A. Jansen

First Use Date

Aug 6, 2020

Filing Date

Jun 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

8 Trademark

Serial Number: 90785551 • Registration: 7762644

8 is a trademark filed by In8bio, Inc. on June 21, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

In8bio, Inc. (6 trademarks)

New York, NY 10118

Entity Type: 03

Trademark Details

Filing Date

June 21, 2021

Registration Date

April 15, 2025

First Use Anywhere

August 6, 2020

First Use in Commerce

August 6, 2020

Published for Opposition

November 2, 2021

Goods & Services

pharmaceutical preparations, namely, oncological preparations; reagent, diagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression

development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment

research, development, and evaluation of new products; pharmaceutical, medicine, and vaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 25, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 25, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 7, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 7, 2025 AITU
USE AMENDMENT FILED
Dec 30, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 30, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jun 21, 2024 EX5G
SOU EXTENSION 5 FILED
Jun 21, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 21, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2023 EXRA
SOU EXTENSION 4 GRANTED
Dec 15, 2023 EX4G
SOU EXTENSION 4 FILED
Dec 15, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jun 26, 2023 EX3G
SOU EXTENSION 3 FILED
Jun 26, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2022 EXRA
SOU EXTENSION 2 GRANTED
Nov 10, 2022 EX2G
SOU EXTENSION 2 FILED
Nov 10, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 10, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jun 22, 2022 EX1G
SOU EXTENSION 1 FILED
Jun 22, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 22, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 5, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 5, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 5, 2021 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 27, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 7, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2021 NWOS
NEW APPLICATION ENTERED
Jun 24, 2021 NWAP